Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pCAGGS_L_EBOV Citations (3)

Originally described in: An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
Nelson EV, Pacheco JR, Hume AJ, Cressey TN, Deflube LR, Ruedas JB, Connor JH, Ebihara H, Muhlberger E Antiviral Res. 2017 Aug 12;146:21-27. doi: 10.1016/j.antiviral.2017.08.005.
PubMed Journal

Articles Citing pCAGGS_L_EBOV

Articles
A Chimeric Lloviu Virus Minigenome System Reveals that the Bat-Derived Filovirus Replicates More Similarly to Ebolaviruses than Marburgviruses. Manhart WA, Pacheco JR, Hume AJ, Cressey TN, Deflube LR, Muhlberger E. Cell Rep. 2018 Sep 4;24(10):2573-2580.e4. doi: 10.1016/j.celrep.2018.08.008. PubMed

Associated Plasmids

Identification of RUVBL1 and RUVBL2 as Novel Cellular Interactors of the Ebola Virus Nucleoprotein. Morwitzer MJ, Tritsch SR, Cazares LH, Ward MD, Nuss JE, Bavari S, Reid SP. Viruses. 2019 Apr 23;11(4). pii: v11040372. doi: 10.3390/v11040372. PubMed
Development of an EBOV MiniG plus system as an advanced tool for anti-Ebola virus drug screening. Hsu CJ, Chen CH, Chen WT, Liu PC, Chang TY, Lin MH, Chen CC, Chen HY, Huang CH, Cheng YH, Sun JR. Heliyon. 2023 Nov 11;9(11):e22138. doi: 10.1016/j.heliyon.2023.e22138. eCollection 2023 Nov. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.